Literature DB >> 34106738

Integrating Behavioral Health and Serious Illness Care in a Post-COVID-19 Environment.

Daniel Shalev1, Brigitta Spaeth-Rublee1, Stephanie Cheung1, Jon A Levenson1, Harold Alan Pincus1.   

Abstract

Individuals with serious medical illnesses experience high rates of comorbid behavioral health conditions. Behavioral health comorbidity affects outcomes in serious illness care. Despite this consequence, behavioral health remains siloed from serious illness care. Prior to the COVID-19 pandemic, the authors presented a conceptual model of behavioral health integration into serious illness care. In this column, the authors reflect on this model in the context of the challenges and opportunities posed by COVID-19.

Entities:  

Keywords:  Coronavirus/COVID-19; Quality of care; palliative care; serious illness

Mesh：

Year:  2021        PMID： 34106738      PMCID： PMC9132058          DOI： 10.1176/appi.ps.202000903

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN： 1075-2730            Impact factor:   4.157


  9 in total

1.  A Model to Improve Behavioral Health Integration into Serious Illness Care.

Authors:  Stephanie Cheung; Brigitta Spaeth-Rublee; Daniel Shalev; Mingjie Li; Mary Docherty; Jon Levenson; Harold Alan Pincus
Journal:  J Pain Symptom Manage       Date:  2019-06-05       Impact factor: 3.612

2.  Bridging the Behavioral Health Gap in Serious Illness Care: Challenges and Strategies for Workforce Development.

Authors:  Daniel Shalev; Mary Docherty; Brigitta Spaeth-Rublee; Nicole Khauli; Stephanie Cheung; Jon Levenson; Harold Alan Pincus
Journal:  Am J Geriatr Psychiatry       Date:  2019-09-07       Impact factor: 4.105

3.  National Consensus Project Clinical Practice Guidelines for Quality Palliative Care Guidelines, 4th Edition.

Authors:  Betty R Ferrell; Martha L Twaddle; Amy Melnick; Diane E Meier
Journal:  J Palliat Med       Date:  2018-09-04       Impact factor: 2.947

4.  Unmet social care needs of people living with and beyond cancer: prevalence and predictors from an English longitudinal survey.

Authors:  Katerina Gousia; Ann-Marie Towers
Journal:  Psychooncology       Date:  2021-02-25       Impact factor: 3.894

5.  Comparative health care use patterns of people with schizophrenia near the end of life: a population-based study in Manitoba, Canada.

Authors:  Harvey M Chochinov; Patricia J Martens; Heather J Prior; Maia S Kredentser
Journal:  Schizophr Res       Date:  2012-08-19       Impact factor: 4.939

6.  Association of Psychiatric Disorders With Mortality Among Patients With COVID-19.

Authors:  Katlyn Nemani; Chenxiang Li; Mark Olfson; Esther M Blessing; Narges Razavian; Ji Chen; Eva Petkova; Donald C Goff
Journal:  JAMA Psychiatry       Date:  2021-04-01       Impact factor: 21.596

7.  The Creation of a Psychiatry-Palliative Care Liaison Team: Using Psychiatrists to Extend Palliative Care Delivery and Access During the COVID-19 Crisis.

Authors:  Daniel Shalev; Shunichi Nakagawa; Oliver M Stroeh; Melissa R Arbuckle; Rebecca Rendleman; Craig D Blinderman; Peter A Shapiro
Journal:  J Pain Symptom Manage       Date:  2020-06-13       Impact factor: 3.612

8.  Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020.

Authors:  Mark É Czeisler; Rashon I Lane; Emiko Petrosky; Joshua F Wiley; Aleta Christensen; Rashid Njai; Matthew D Weaver; Rebecca Robbins; Elise R Facer-Childs; Laura K Barger; Charles A Czeisler; Mark E Howard; Shantha M W Rajaratnam
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-08-14       Impact factor: 17.586

9.  Supporting the well-being of health care providers during the COVID-19 pandemic: The CopeColumbia response.

Authors:  Claude A Mellins; Laurel E S Mayer; Deborah R Glasofer; Michael J Devlin; Anne Marie Albano; Sara Siris Nash; Erin Engle; Colleen Cullen; Warren Y K Ng; Anna E Allmann; Elizabeth M Fitelson; Aaron Vieira; Robert H Remien; Patrice Malone; Milton L Wainberg; Lourival Baptista-Neto
Journal:  Gen Hosp Psychiatry       Date:  2020-09-09       Impact factor: 3.238
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.